Manidipine Zydus

Manidipine Dihydrochloride, the active ingredient in Manidipine Zydus, is a calcium channel blocker presented as a tablet for oral use. It lowers elevated blood pressure in adult patients with hypertension.

GNH USA supplies Manidipine Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manidipine is a dihydropyridine calcium‑channel blocker used in the management of high‑blood‑pressure disorders.

Hypertension (essential): reduces systolic and diastolic blood pressure in adults with essential hypertension. Isolated systolic hypertension: helps lower elevated systolic pressure in older patients. Diastolic hypertension: assists in decreasing elevated diastolic pressure.

Manidipine may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache reported. - Flushing: transient facial warmth. - Peripheral edema: swelling of ankles or feet. - Dizziness: sensation of light‑headedness. - Tachycardia: increased heart rate. - Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Angioedema: swelling of lips, tongue or airway. - Hepatic dysfunction: elevated liver enzymes. - Myocardial infarction: rare occurrence of heart attack. - Arrhythmia: abnormal heart rhythm. - Allergic reaction: rash, itching, or anaphylaxis.

Before initiating therapy with Manidipine, several precautionary measures should be considered.

Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. Gradual dose titration: start with low dose and increase gradually as tolerated. Hepatic impairment: use with caution in patients with liver disease. Renal impairment: adjust therapy if severe renal dysfunction is present. Concomitant antihypertensives: monitor for additive blood‑pressure lowering effects. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Manidipine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise plasma levels and increase risk of hypotension. - Grapefruit juice: can inhibit metabolism leading to higher drug exposure. - Concurrent use with other potent antihypertensives: may cause excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower drug concentrations and reduce effect. - NSAIDs: may blunt antihypertensive response.